Soluble TREM2 suppresses neuronal activity
This study demonstrates that soluble TREM2 (sTREM2) acts as a rapid, physiological suppressor of neuronal activity by binding to CD73 to activate purinergic microglia–neuron signaling, thereby protecting against excitotoxicity and offering a potential therapeutic target for Alzheimer's disease and epilepsy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The brain is a vast network of electrical signals, where billions of cells communicate to create thought, memory, and movement. For this system to work, the activity of these cells must be kept within a narrow, healthy range. Too little activity leads to a loss of function, but too much can be dangerous, causing the cells to become overworked and damaged. Scientists have long known that a specific type of immune cell in the brain, called a microglia, helps keep this balance by cleaning up debris and pruning unnecessary connections. These microglia act like the brain's maintenance crew, constantly monitoring the environment. Recently, researchers discovered that these cells produce a specific protein fragment, a piece of a larger receptor molecule, which floats freely in the fluid surrounding the brain cells. While this fragment was known to rise in levels during diseases like Alzheimer's, its exact job in a healthy brain remained a mystery. The question was whether this floating piece was merely a sign of trouble or if it played an active role in controlling how hard the brain cells worked.
A team of researchers at the Technical University of Munich and several other institutions set out to solve this puzzle by watching what happened when they introduced this floating protein directly into the brains of living mice. They focused on the hippocampus, a region critical for memory, and used a special microscope to watch individual brain cells light up as they fired electrical signals. When the scientists applied the soluble protein, known as sTREM2, to the brain tissue, they observed an immediate and reversible change. The neurons, which had been firing spontaneously, suddenly slowed down. The activity did not disappear entirely, but it dropped significantly, and when the protein was washed away, the cells returned to their normal rhythm. This showed that the protein acts as a rapid brake on brain activity, capable of turning down the volume of the brain's electrical chatter within minutes.
To understand how this worked, the researchers tested whether the protein acted directly on the neurons or if it needed help from the microglia. They removed the microglia from some mice and tried the experiment again. Without these immune cells present, the protein had no effect; the neurons continued to fire at their usual pace. This proved that the protein does not touch the neurons directly. Instead, it relies on the microglia to do the work. The team discovered that the protein binds to a specific enzyme on the surface of the microglia called CD73. This enzyme is part of a chain reaction that converts a chemical signal released by active neurons into a different chemical, adenosine. Adenosine is a natural substance that tells neurons to calm down. By binding to CD73, the protein appears to boost this calming signal, effectively telling the neurons to slow their firing rate.
The researchers then looked at what happens when this system is broken. They studied mice that lacked the gene for the protein entirely. These animals showed higher levels of brain activity than normal mice, with many neurons firing more frequently. When the scientists applied the protein to these mice, it successfully lowered their activity back to normal levels. Conversely, they created a different group of mice that produced extra amounts of the protein naturally. These mice had lower baseline activity than normal mice, and when the scientists tried to add more protein, it made no difference because the system was already maxed out. They also found that if they blocked the protein in the mice that produced extra amounts, the brain activity rose back up. This confirmed that the amount of this floating protein in the brain directly determines how active the neurons are.
The study also explored whether this mechanism could protect the brain from dangerous overactivity, such as seizures. When the researchers induced seizures in mice using a chemical trigger, the mice with extra protein had fewer seizure events and less severe symptoms. In contrast, mice lacking the protein suffered more frequent and intense seizures. The team found that they could fix the seizure problem in the protein-deficient mice by giving them a drug that mimics the calming chemical adenosine, proving that the protein works through this specific pathway to protect the brain. Finally, they tested if this protection extended to the early stages of Alzheimer's disease, where toxic protein clumps are known to cause neurons to fire uncontrollably. When they applied these toxic clumps to healthy brain tissue, the neurons became hyperactive. However, if the soluble protein was present, it prevented this overactivation, keeping the neurons calm despite the presence of the toxic clumps.
These findings suggest that the floating protein is not just a passive marker of disease but an active guardian of brain stability. It acts as a fast-acting regulator that uses the brain's immune cells to keep neuronal activity in check. By boosting the brain's natural calming signals, it can prevent the kind of electrical storms that lead to seizures and the hyperactivity seen in the early stages of Alzheimer's. The research indicates that maintaining the right levels of this protein could be a key strategy for protecting the brain from damage caused by excessive activity, offering a new perspective on how the brain's immune system and its electrical network work together to stay healthy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.